Dr. Wenhua Yu (Jocelyn) focuses her legal practice on assisting clients in the life science industry in maximizing intellectual property (IP) protection and leveraging IP rights in business strategies and international transactions. She services clients ranging from biotech start-ups to the largest international pharmaceutical companies.
Jocelyn assists clients in constructing, developing, and managing global patent portfolios. She has extensive experience in designing, preparing, and prosecuting patent applications in the United States and in countries around the world. Her main technology areas include immunotherapies (including antibodies, immunocytokines, and next-generation antibody platforms), gene therapies (including mRNA-based, viral or nonviral vector-based therapeutics), cell therapies (including CAR-T, stem cell, iPSC, CAR-NK therapeutics), diagnostics and precision medicine, gene editing (CRISPR), natural peptide platforms, and microbial engineering technology. She also frequently conducts due diligence investigations and provides legal opinions to assist with clients' IP, R&D, and business strategies, including patent evaluations, IP landscape searches, patentability opinions, validity opinions, and freedom-to-operate opinions.
Jocelyn also assists biotech and pharmaceutical companies in constructing technology transactions and collaborations (including IP licensing transactions, funded research, and joint research and development collaborations) with a focus on cross-border transactions between U.S. and Asian markets. She frequently assists clients in negotiating, reviewing, and drafting various commercial agreements involving IP rights and conducts legal, technical, IP, and pharmaceutical regulatory compliance due diligence investigations to support the transactions.
- October 27, 2022
Practical Considerations in Continuation/Divisional Patent Application Practice
- September 28, 2022
Key topics for negotiation in Cross-the-Border Out-Licensing of Pharmaceutical Assets and Case Studies (Presentation in Mandarin)
- January 25, 2022
Key Topics For Negotiation in Life Science Licensing Transactions
- November 7, 2018
Licensing Fundamentals for Business Executives and Startups
- Northwestern University (J.D. 2016); Pennsylvania State University (Ph.D. in Genetics 2010); Wuhan University, China (B.S. in Pharmacology 2004)
- California and registered to practice before the U.S. Patent and Trademark Office